Aptamer–protein interactions: from regulation to biomolecular detection
C Ji, J Wei, L Zhang, X Hou, J Tan, Q Yuan… - Chemical …, 2023 - ACS Publications
Serving as the basis of cell life, interactions between nucleic acids and proteins play
essential roles in fundamental cellular processes. Aptamers are unique single-stranded …
essential roles in fundamental cellular processes. Aptamers are unique single-stranded …
Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection
Tuberculosis (TB) is the leading infectious cause of mortality worldwide, due in part to a
limited understanding of its clinical pathogenic spectrum of infection and disease …
limited understanding of its clinical pathogenic spectrum of infection and disease …
[HTML][HTML] Aptamers in the therapeutics and diagnostics pipelines
Aptamers are short single-stranded DNA or RNA oligonucleotides that can selectively bind
to small molecular ligands or protein targets with high affinity and specificity, by acquiring …
to small molecular ligands or protein targets with high affinity and specificity, by acquiring …
[HTML][HTML] Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents
JC Rohloff, AD Gelinas, TC Jarvis, UA Ochsner… - … Therapy-Nucleic Acids, 2014 - cell.com
Limited chemical diversity of nucleic acid libraries has long been suspected to be a major
constraining factor in the overall success of SELEX (Systematic Evolution of Ligands by …
constraining factor in the overall success of SELEX (Systematic Evolution of Ligands by …
[HTML][HTML] Human tuberculosis and Mycobacterium tuberculosis complex: A review on genetic diversity, pathogenesis and omics approaches in host biomarkers …
Mycobacterium tuberculosis complex (MTBC) refers to a group of mycobacteria
encompassing nine members of closely related species that causes tuberculosis in animals …
encompassing nine members of closely related species that causes tuberculosis in animals …
[HTML][HTML] Chemical modification of aptamers for increased binding affinity in diagnostic applications: Current status and future prospects
JP Elskens, JM Elskens, A Madder - International journal of molecular …, 2020 - mdpi.com
Aptamers are short single stranded DNA or RNA oligonucleotides that can recognize
analytes with extraordinary target selectivity and affinity. Despite their promising properties …
analytes with extraordinary target selectivity and affinity. Despite their promising properties …
[HTML][HTML] Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
TJ Scriba, A Penn-Nicholson, S Shankar… - PLoS …, 2017 - journals.plos.org
Our understanding of mechanisms underlying progression from Mycobacterium tuberculosis
infection to pulmonary tuberculosis disease in humans remains limited. To define such …
infection to pulmonary tuberculosis disease in humans remains limited. To define such …
Advances in targeted proteomics and applications to biomedical research
Targeted proteomics technique has emerged as a powerful protein quantification tool in
systems biology, biomedical research, and increasing for clinical applications. The most …
systems biology, biomedical research, and increasing for clinical applications. The most …
Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease
D Goletti, MR Lee, JY Wang, N Walter… - …, 2018 - Wiley Online Library
Tuberculosis (TB) remains a devastating disease, yet despite its enormous toll on global
health, tools to control TB are insufficient and often outdated. TB Biomarkers (TB‐BM) would …
health, tools to control TB are insufficient and often outdated. TB Biomarkers (TB‐BM) would …
[HTML][HTML] Advances in aptamer-based biomarker discovery
The discovery and identification of biomarkers promote the rational and fast development of
medical diagnosis and therapeutics. Clinically, the application of ideal biomarkers still is …
medical diagnosis and therapeutics. Clinically, the application of ideal biomarkers still is …